US Broker Ratings

Avadel Pharmaceuticals (AVDL) Stock Analysis: Navigating Potential Amidst a 54.9% Revenue Growth Surge

Avadel Pharmaceuticals plc (NASDAQ: AVDL) has been capturing the attention of investors within the healthcare sector, specifically those focusing on specialty and generic drug manufacturers. This Ireland-based biopharmaceutical company, with..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating Growth and Valuation with a 3.34% Potential Upside

Phibro Animal Health Corporation (NASDAQ: PAHC) stands out in the healthcare sector as a key player in the drug manufacturers – specialty and generic industry. With a market capitalization of..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: A Biotech Gem with 65% Upside Potential

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a burgeoning name in the healthcare sector, is capturing the attention of investors with its promising prospects in the biotechnology industry. Specializing in innovative treatments..

Nutex Health Inc. (NUTX) Stock Report: Exploring a 56.82% Potential Upside in the Booming Healthcare Sector

Nutex Health Inc. (NASDAQ: NUTX) has emerged as a noteworthy player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $1.13 billion, Nutex..

Beta Bionics, Inc. (BBNX) Stock Analysis: A 92.67% Upside Potential for Innovative Diabetes Solutions

For investors seeking exposure to the cutting-edge healthcare sector, Beta Bionics, Inc. (NASDAQ: BBNX) offers a compelling opportunity with significant growth potential. This commercial-stage medical device company, based in Irvine,..

Intellia Therapeutics (NTLA) Stock Analysis: Exploring a 40% Upside Potential in Gene Editing Innovations

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a trailblazer in the biotechnology sector, is captivating investor attention with its promising gene editing technologies and substantial growth potential. Headquartered in Cambridge, Massachusetts, Intellia..

CureVac N.V. (CVAC) Investor Outlook: Navigating the Biotechnology Terrain Amidst Strategic Acquisitions

CureVac N.V. (NASDAQ: CVAC), a prominent player in the biotechnology sector, has been navigating a complex landscape characterized by significant innovation and strategic shifts. As of December 18, 2025, the..

Geron Corporation (GERN) Stock Analysis: Unveiling a 155% Upside Potential in Biotech

Geron Corporation (NASDAQ: GERN), a burgeoning name in the biotechnology sector, has recently captured the attention of investors with its significant upside potential. With a current market cap of $900.08..

Pharvaris N.V. (PHVS) Stock Analysis: Navigating a 65% Upside in Biotech Innovations

Pharvaris N.V. (PHVS), a Swiss-based biopharmaceutical company, has emerged as a compelling player in the biotechnology sector, focusing on developing therapies for rare diseases. With a current market capitalization of..

Embecta Corp. (EMBC) Stock Analysis: Unlocking 37% Potential Upside in the Healthcare Sector

Embecta Corp. (NASDAQ: EMBC), a prominent player in the healthcare sector, is gaining attention from investors due to its promising potential for a 37.97% upside. Specializing in medical instruments and..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: A 275% Potential Upside That Investors Can’t Ignore

For investors keen on tapping into the dynamic world of healthcare innovation, Akebia Therapeutics, Inc. (NASDAQ: AKBA) presents a particularly compelling opportunity. With its focus on developing therapeutics for kidney..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Exploring a 52.60% Potential Upside in the Biotech Arena

Nurix Therapeutics, Inc. (NASDAQ: NRIX), a promising player in the biotechnology sector, is capturing investor attention with its potential for significant upside. With a market capitalization of $1.97 billion, this..

HealthStream, Inc. (HSTM) Stock Analysis: Uncovering a 51% Upside Potential for Investors

HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the Health Information Services industry, stands out as a compelling investment opportunity for those looking to navigate the healthcare sector. Headquartered in..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Unveiling a 151% Potential Upside in the Biotechnology Sector

For investors seeking promising opportunities in the biotechnology sector, Niagen Bioscience, Inc. (NAGE) presents an intriguing prospect with a substantial potential upside. Listed in the healthcare sector and focused on..

Zymeworks Inc. (ZYME) Stock Analysis: Strong Buy Ratings and a Promising 51% Upside Potential

Zymeworks Inc. (NASDAQ: ZYME) stands out as a formidable player in the biotech sector, driven by its innovative approach to cancer and autoimmune disease therapies. With a market capitalization of..

Bicara Therapeutics (BCAX) Investor Outlook: A 74.97% Potential Upside in the Biotech Sector

Bicara Therapeutics Inc. (NASDAQ: BCAX), a burgeoning player in the biotechnology sector, has captured the attention of investors with its promising clinical-stage developments and significant potential upside. With a market..

AMN Healthcare Services Inc (AMN): Navigating Growth Amidst Sector Challenges with a 6.36% Potential Upside

AMN Healthcare Services Inc (NYSE: AMN) stands as a pivotal player in the U.S. healthcare sector, offering a broad array of workforce solutions and staffing services. With a market capitalization..

CareDx, Inc. (CDNA) Stock Analysis: A Healthcare Innovator with 4.66% Upside Potential

CareDx, Inc. (NASDAQ: CDNA) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $1.12 billion, this U.S.-based company has carved..

Paycom Software, Inc. (PAYC): Analyst Consensus Points to 36% Potential Upside

Paycom Software, Inc. (NASDAQ: PAYC) has garnered significant attention in the technology sector, particularly within the software application industry. Based in Oklahoma City, Oklahoma, Paycom is known for its robust..

Ringcentral, Inc. (RNG) Stock Analysis: Growth Potential with a 27.67% Upside

Ringcentral, Inc. (NYSE: RNG) is increasingly drawing the attention of investors who are keen on tapping into the expanding realm of cloud-based communications solutions. As a key player in the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds